Amanda Enyeart and Lisa Schmitz Mazur wrote this bylined article explaining how the HHS Office of Inspector General used a survey by the Electronic Health Records (EHR) Incentive Program run by Centers for Medicare and Medicaid Services (CMS) to conclude that CMS made $729 million in inappropriate EHR incentive payments to physicians out of some $6 billion in such payments during the review period.
OIG Reports More than $731 Million in Inappropriate Medicare Meaningful Use Payments
By Amanda Enyeart and Lisa Schmitz Mazur on July 18, 2017
Tags: Centers for Medicare and Medicaid Services (CMS), Certified Electronic Health Record Technology (CEHRT), Electronic Health Record Incentive Program, Electronic Health Records (EHR), Eligible Professionals (EPs), False Claims Act, Medicaid, Medicare, Office of Inspector General of the US Department of Health and Human Services (OIG), Quality Payment Program, US Department of Justice (DOJ)
Amanda EnyeartAmanda Enyeart maintains a general health industry and regulatory practice, focusing on fraud and abuse, information technology and digital health matters. Amanda advises health care industry clients in all aspects of software licenses and other agreements for the acquisition electronic health record (EHR) systems and other mission critical health IT. Amanda’s health care IT transactional experience also includes advising clients with respect to software development, maintenance, service and outsourced hosting arrangements, including cloud-computing transactions. Read Amanda Enyeart's full bio.
Lisa Schmitz MazurLisa Schmitz Mazur advises health care providers and technology companies on a variety of legal, regulatory and compliance matters with a particular focus on digital health topics, including telehealth, telemedicine, mobile health and consumer wellness. Lisa advises a variety of health care providers and technology companies involved in “digital health,” including assisting clients in developing and implementing telemedicine programs by advising on issues related to professional licensure, scope of practice, informed consent, prescribing and reimbursement. Lisa helps clients identify and understand the relevant legal issues, and develop and implement practical, forward-thinking solutions and strategies that meet the complex and still-evolving digital health regulatory landscape. Read Lisa Schmitz Mazur's full bio.
Related Posts
- American Rescue Plan Act of 2021: Key Healthcare Provisions
- Drug Discount Plan Remains Target for Possible Legislation
- Coverage of COVID-19 Testing and the End of the COVID-19 Emergency
- How Employers Need to Prepare for the End of the COVID Public Health Emergency and National Emergency
- Prescription Drug Data Reporting: What the “Good Faith Compliance” Extension Really Means for Self-Funded Group Health Plans
BLOG EDITORS
STAY CONNECTED
TOPICS
ARCHIVES
RECENT POSTS
- 2024 Chart of Healthcare Regulations
- Potential Election Year Shakeup: Regulatory Implications of the Congressional Review Act
- Lessons from Ryan S. v. UnitedHealth Group for the 2023 MHPAEA Proposed Rule
- Hospital Settles With OCR for $4.75 Million Over HIPAA Violations
- Key Takeaways | How to Prepare for New State Health Privacy Laws
